{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/contraception-sterilization/management/tubal-occlusion/","result":{"pageContext":{"chapter":{"id":"189638ba-d294-56be-9c03-2d034c897672","slug":"tubal-occlusion","fullItemName":"Scenario: Tubal occlusion","depth":2,"htmlHeader":"<!-- begin field e21a978b-5445-4b2d-94e7-b2391dc00576 --><h2>Scenario: Tubal occlusion</h2><!-- end field e21a978b-5445-4b2d-94e7-b2391dc00576 -->","summary":"Covers the advantages, disadvantages, risks, and efficacy of tubal occlusion (female sterilization).","htmlStringContent":"<!-- begin item e4684593-ef19-4971-b269-cb842ba49e02 --><!-- begin field eec4d43a-6699-4f44-8d57-acbc015b90bd --><p>From age 18 years to 60 years (Female).</p><!-- end field eec4d43a-6699-4f44-8d57-acbc015b90bd --><!-- end item e4684593-ef19-4971-b269-cb842ba49e02 -->","topic":{"id":"8476bca2-26f3-58bf-9534-43bcd97620c4","topicId":"687784f1-c4f9-49e1-b81b-030c7fcf147a","topicName":"Contraception - sterilization","slug":"contraception-sterilization","lastRevised":"Last revised in June 2016","chapters":[{"id":"0a0eec74-d846-559b-9873-f4c72e00d5af","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"3180d0e4-2338-5fcd-b4b5-614d98f1acca","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"176d72c6-7d31-5475-9da0-78510905dad1","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"c63caa3e-3aaf-5b63-822c-8ececa2d150b","slug":"changes","fullItemName":"Changes"},{"id":"95258b7f-0b95-5dc0-8ffa-c171d269ba0a","slug":"update","fullItemName":"Update"}]},{"id":"81b04194-d074-5c40-ba4f-eaa5222ad594","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d87fe99a-fa45-51e5-82fc-64ac4254370b","slug":"goals","fullItemName":"Goals"},{"id":"50d0b72e-30a1-5fe6-b65e-8d6fe12af0f7","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2574066e-369c-54f1-9929-2706d8798924","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1080840c-8b97-511c-b653-383403be4bf8","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"198a6919-897f-59e9-83d7-a78a592e6b9c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - options for local implementation"},{"id":"7a718378-90fe-50b7-9256-240d1ab73099","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"99ee8781-8de8-517d-9a85-cbaf43b54009","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"28b2eb26-8068-5798-b284-630c74c6e068","slug":"definition","fullItemName":"Definition"}]},{"id":"e1a35d66-2974-5ebd-bd40-b9f9f6a4f455","fullItemName":"Management","slug":"management","subChapters":[{"id":"06f23be5-9ef5-57b0-ac71-f54f22f83fce","slug":"vasectomy","fullItemName":"Scenario: Vasectomy"},{"id":"189638ba-d294-56be-9c03-2d034c897672","slug":"tubal-occlusion","fullItemName":"Scenario: Tubal occlusion"}]},{"id":"22002e8b-15ca-5d82-9b91-ab290ae04082","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"283203e1-c2c2-50d1-9288-b5621f5d609b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"78d7ee02-34ec-530f-816e-7eaba26a9b14","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3fa88a6b-0352-5bc3-a220-8d595e4d36ab","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"9abe6ea7-de64-5ab7-ad5f-a8ce4daf5677","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d293281e-afd9-5290-818c-49d8d8b45b9d","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"bb5349c5-7e0c-503f-9f1b-30814b72c0ae","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"9acf78a7-31d4-5a24-8e6e-93ab3cdaf074","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e1a35d66-2974-5ebd-bd40-b9f9f6a4f455","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"88314959-c63e-5255-8adb-ed31d6333c20","slug":"assessment","fullItemName":"Assessment","depth":3,"htmlHeader":"<!-- begin field a41c58ce-1aae-45e6-be13-87a7e106aadc --><h3>How should I assess a woman considering tubal occlusion?</h3><!-- end field a41c58ce-1aae-45e6-be13-87a7e106aadc -->","summary":null,"htmlStringContent":"<!-- begin item baa19262-2e47-4393-b298-01448ff63573 --><!-- begin field 573c8c4a-b67b-4e32-a8d0-ea65f062f5fc --><ul><li>See the section on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/management/assessment-for-specific-contraceptive-methods/#sterilization\">How should I assess someone who is considering sterilization?</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/\">Contraception - assessment</a>.</li><li>In addition, the partner's suitability for sterilization should be assessed, as the couple's clinical history, present symptoms, and/or examination findings may influence which partner goes forward to have sterilization.</li></ul><!-- end field 573c8c4a-b67b-4e32-a8d0-ea65f062f5fc --><!-- end item baa19262-2e47-4393-b298-01448ff63573 -->","subChapters":[]},{"id":"5d3f9e2b-104b-5467-a597-09054da5ab19","slug":"information-advice","fullItemName":"Information and advice","depth":3,"htmlHeader":"<!-- begin field 095b836f-95e6-4314-a616-d222a7cab9a7 --><h3>What information and advice should I give to a woman considering tubal occlusion?</h3><!-- end field 095b836f-95e6-4314-a616-d222a7cab9a7 -->","summary":null,"htmlStringContent":"<!-- begin item 8699a12e-459c-41c8-ba39-20b8f98ba486 --><!-- begin field 101678a4-3413-472c-a5cc-089c36b585e8 --><ul><li><strong>Give advice and written information about:</strong><ul><li>The <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-sterilization/management/tubal-occlusion/#advantages-disadvantages-risks-of-tubal-occlusion\">advantages, disadvantages, and risks</a> of tubal occlusion. </li><li>The <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-sterilization/management/tubal-occlusion/#efficacy\">efficacy</a> of tubal occlusion. </li><li>Alternative long-term reversible methods of contraception, including information on the advantages, disadvantages, and relative efficacy of each method. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/\">Contraception - assessment</a>.</li><li>The success rates associated with reversal, should this procedure be necessary. Advise that:<ul><li>The NHS does not routinely provide reversal operations.</li><li>The success of reversal procedures depends on a number of factors including the age of the woman, the method used for tubal occlusion, and the method used for tubal re-anastomosis. Pregnancy rates following reversal range from 31% to 92%.  </li></ul></li><li>The need to use effective contraception until the tubal occlusion procedure, and to continue until 4 weeks after the procedure (3 months after hysteroscopic sterilization).</li><li>The risk of ectopic pregnancy should tubal occlusion fail. <ul><li>The risk varies depending on the method used, but the 10 year cumulative probability of ectopic pregnancy ranges from 2.4-7.3 per 1000 procedures.</li></ul></li></ul></li><li>Also inform the woman that:<ul><li>Tubal occlusion can be performed at any time during the menstrual cycle, provided that the clinician is confident that the woman has used effective contraception up to the day of the operation.<ul><li>If this is not the case, the operation should be deferred until the start of the start of the subsequent cycle.</li><li>A pregnancy test must be performed before the operation to exclude the possibility of a pre-existing pregnancy. However, a negative test does not exclude the possibility of a luteal-phase pregnancy (where the ovum has already passed the site of occlusion).</li></ul></li></ul></li><li>After the operation, women should be advised of the method of tubal occlusion actually used, and of any complications that occurred during the procedure.</li><li>The Family Planning Association provides a useful <a href=\"http://www.fpa.org.uk/sites/default/files/male-and-female-sterilisation-your-guide.pdf\" data-hyperlink-id=\"d546fc43-1b9b-49d9-813c-a98c00e3842b\">leaflet</a> with information on female sterilization.</li><li>Provide <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-sterilization/management/tubal-occlusion/#follow-up-aftercare\">follow up and aftercare</a> advice.</li></ul><!-- end field 101678a4-3413-472c-a5cc-089c36b585e8 --><!-- end item 8699a12e-459c-41c8-ba39-20b8f98ba486 -->","subChapters":[{"id":"c0fae041-0a96-5f2b-ad23-eb554e13d34c","slug":"basis-for-recommendation-d64","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field cb21f081-b4c8-4261-a4bf-0e757106e519 --><h4>Basis for recommendation</h4><!-- end field cb21f081-b4c8-4261-a4bf-0e757106e519 -->","summary":null,"htmlStringContent":"<!-- begin item d645e611-f233-488e-9a76-6bd3b24c01fc --><!-- begin field 0c5a86fd-b87b-446f-b537-a9a3b44b58e5 --><div>These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guideline <em>Male and female sterilisation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-sterilization/references/\">FSRH, 2014</a>], and an information leaflet published by the Family Planning Association, <em>Your guide to male and female sterilisation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-sterilization/references/\">FPA, 2015</a>].</div><!-- end field 0c5a86fd-b87b-446f-b537-a9a3b44b58e5 --><!-- end item d645e611-f233-488e-9a76-6bd3b24c01fc -->","subChapters":[]}]},{"id":"a3fd365e-5a26-5c05-ae86-38f2b1f1b5a1","slug":"advantages-disadvantages-risks-of-tubal-occlusion","fullItemName":"Advantages, disadvantages, and risks of tubal occlusion","depth":3,"htmlHeader":"<!-- begin field a91762e8-496d-476d-bbdd-4d389348b606 --><h3>What are the advantages, disadvantages, and risks associated with tubal occlusion?</h3><!-- end field a91762e8-496d-476d-bbdd-4d389348b606 -->","summary":null,"htmlStringContent":"<!-- begin item 913bdfac-4d97-4655-9eb3-de3a94c612b3 --><!-- begin field d21721b9-8cdf-4963-9a43-d120700242ac --><h4>Advantages</h4><ul><li>Tubal occlusion is very effective in preventing pregnancy.<ul><li>It has a lifetime failure rate of about 1 in 200 women.</li><li>If a Filshie clip is used (the most common method used in the UK) the failure rate 10 years after the procedure may be lower (1 in 333–500 women).</li></ul></li><li>It is permanent.</li><li>Sex need not be interrupted to use contraception.</li></ul><h4>Disadvantages</h4><ul><li>Tubal occlusion requires a surgical procedure.</li><li>People may regret having had the procedure:<ul><li>The assessment process is designed to ensure that people at risk of regret are identified and fully informed about alternative long-acting reversible contraceptive methods.</li></ul></li><li>It cannot easily be reversed, and the NHS does not routinely offer reversal procedures.</li><li>It does not protect against sexually transmitted infections.</li><li>It can fail, but this is uncommon.</li></ul><h4>Risks</h4><ul><li>Tubal occlusion is performed using laparoscopy (or laparotomy). The risk of a major complication with laparoscopy (injury to bowel, bladder, or blood vessels requiring laparotomy or leading to death) is about 2 per 1000 procedures. The risk of death with a laparoscopy is 1 in 12,000 procedures.<ul><li>The risk of complications and need for laparotomy are increased by previous abdominal or pelvic surgery, previous pelvic inflammatory disease, and obesity.</li></ul></li><li>If tubal occlusion fails, the resulting pregnancy may be ectopic.</li><li>Women should be reassured that tubal occlusion is not associated with an increased risk of heavier or irregular periods when performed after 30 years of age.<ul><li>There is little information on the effect on menstruation when tubal occlusion is performed for women less than 30 years of age.</li></ul></li><li>The procedure requires a general anaesthetic.</li></ul><!-- end field d21721b9-8cdf-4963-9a43-d120700242ac --><!-- end item 913bdfac-4d97-4655-9eb3-de3a94c612b3 -->","subChapters":[{"id":"9e7883b6-afa3-5921-95e7-7d20289cda09","slug":"basis-for-recommendation-01e","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a93de96a-7df6-4b25-98dc-045ee03fffa2 --><h4>Basis for recommendation</h4><!-- end field a93de96a-7df6-4b25-98dc-045ee03fffa2 -->","summary":null,"htmlStringContent":"<!-- begin item 01eb3af3-d072-49ef-be08-27e9e71db314 --><!-- begin field ea3a9ec9-25f1-4355-9652-229f4b5b8bf6 --><p>These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guideline <em>Male and female sterilisation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-sterilization/references/\">FSRH, 2014</a>].<br></p><!-- end field ea3a9ec9-25f1-4355-9652-229f4b5b8bf6 --><!-- end item 01eb3af3-d072-49ef-be08-27e9e71db314 -->","subChapters":[]}]},{"id":"dabec646-00d1-5598-a8df-a7ae73caab77","slug":"efficacy","fullItemName":"Efficacy","depth":3,"htmlHeader":"<!-- begin field 28fce534-2786-4726-8478-e6bf065ed97f --><h3>How effective is tubal occlusion?</h3><!-- end field 28fce534-2786-4726-8478-e6bf065ed97f -->","summary":null,"htmlStringContent":"<!-- begin item c2ae073f-744c-4d74-ab3c-af0182c4e741 --><!-- begin field aff771eb-ca9d-4430-b76e-047bf8ed39f0 --><ul><li>Tubal occlusion has a lifetime failure rate of about 1 in 200 women.</li><ul><li>If a Filshie clip is used (the most common method used in the UK) the failure rate 10 years after the procedure may be lower (1 in 333–500 women).</li></ul></ul><!-- end field aff771eb-ca9d-4430-b76e-047bf8ed39f0 --><!-- end item c2ae073f-744c-4d74-ab3c-af0182c4e741 -->","subChapters":[{"id":"7735ebe4-80f1-5f0a-8e18-7b5c995839dc","slug":"basis-for-recommendation-f76","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a2f4a1ce-1cf4-417b-9953-ddcdd761eaaa --><h4>Basis for recommendation</h4><!-- end field a2f4a1ce-1cf4-417b-9953-ddcdd761eaaa -->","summary":null,"htmlStringContent":"<!-- begin item f7699444-e6a9-4905-9551-e16ead6f32f8 --><!-- begin field 39895d16-ce2a-4521-aca4-7bd5151e094f --><div>This information is based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guideline <em>Male and female sterilisation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-sterilization/references/\">FSRH, 2014</a>].<br></div><!-- end field 39895d16-ce2a-4521-aca4-7bd5151e094f --><!-- end item f7699444-e6a9-4905-9551-e16ead6f32f8 -->","subChapters":[]}]},{"id":"d7675f10-b0c5-5ed8-bffa-55c8b4f2b1f4","slug":"follow-up-aftercare","fullItemName":"Follow up and aftercare","depth":3,"htmlHeader":"<!-- begin field b236f2d1-8ed2-4d62-a27e-c6d27354c0de --><h3>What follow up and aftercare advice should I give a woman who has undergone tubal occlusion?</h3><!-- end field b236f2d1-8ed2-4d62-a27e-c6d27354c0de -->","summary":null,"htmlStringContent":"<!-- begin item ca696519-510d-4565-ac07-edbb90c99e97 --><!-- begin field ea9680c7-0a0b-4242-85d8-9f2d7ffac565 --><ul><li>Advise women who have undergone tubal occlusion:<ul><li>About appropriate self-care, including: <ul><li>Wound care information if appropriate — keep the incision clean and dry for 1 to 2 days.</li><li>Analgesia for pain or discomfort following the procedure. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a>.</li></ul></li><li>To avoid rigorous physical activity for one week.</li><li>To avoid sex for at least one week.</li><li>When to seek medical help, including: <ul><li>Abdominal pain, especially if accompanied by temperature, loss of appetite, vomiting, and generally feeling unwell — this could indicate a bowel perforation.</li><li>Abdominal pain associated with missed periods — possible ectopic pregnancy.</li><li>A painful, red, swollen, warm calf, or difficult weight-bearing on the leg may indicate deep vein thrombosis. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/deep-vein-thrombosis/\">Deep vein thrombosis</a>.</li><li>Burning and stinging when passing urine, or urinating frequently may indicate urinary tract infection. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/urinary-tract-infection-lower-women/\">Urinary tract infection (lower) - women</a>. </li><li>Red and painful skin around the scars may indicate skin infection. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/cellulitis-acute/\">Cellulitis - acute</a>.</li></ul></li></ul></li><li><span class=\"rangySelectionBoundary\">Inform w</span>omen who have undergone hysteroscopic sterilization that additional contraception will need to be used until testing has confirmed successful placement of the micro-inserts and/or tubal occlusion.</li><li>Inform women who have undergone laparoscopic sterilization that they should continue their combined hormonal contraceptive (CHC) or progestogen-only contraceptive (POP) for seven days after tubal occlusion, omitting the normal pill-free interval if that falls within this time.</li></ul><!-- end field ea9680c7-0a0b-4242-85d8-9f2d7ffac565 --><!-- end item ca696519-510d-4565-ac07-edbb90c99e97 -->","subChapters":[{"id":"38861f36-8bc5-57b1-a2f7-9e2bc060284b","slug":"basis-for-recommendation-de3","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 5439f583-8754-4a5c-9030-6b8c52d89390 --><h4>Basis for recommendation</h4><!-- end field 5439f583-8754-4a5c-9030-6b8c52d89390 -->","summary":null,"htmlStringContent":"<!-- begin item de3d8f34-549c-48ec-a274-03497ab6ad9b --><!-- begin field e1f2760f-bd84-4761-9d61-fd313f2565a0 --><div>These recommendations are based on the Faculty of Sexual and Reproductive Healthcare (FSRH) clinical guideline <em>Male and female sterilisation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-sterilization/references/\">FSRH, 2014</a>], the World Health Organization (WHO) textbook <em>Family Planning</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-sterilization/references/\">WHO, 2011</a>], and an information leaflet published by the Royal College of Obstetricians and Gynaecologists, <em>Recovering well: Information for you after a laparoscopy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-sterilization/references/\">RCOG, 2015</a>].</div><!-- end field e1f2760f-bd84-4761-9d61-fd313f2565a0 --><!-- end item de3d8f34-549c-48ec-a274-03497ab6ad9b -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}